Cytosorbents Corp (CTSO) - Form 8-K Summary
Business Context and Reporting Period
Cytosorbents Corporation, a Delaware corporation trading on the Nasdaq Capital Market under the symbol CTSO, filed this Current Report on May 13, 2026. The filing serves to announce the company's financial results for the quarter ended March 31, 2026, via a press release furnished as Exhibit 99.1.
Key Financial Metrics
The provided Form 8-K text does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. These figures are referenced as being contained within the attached press release (Exhibit 99.1), which is not included in the source text.
Material Changes
The filing text does not provide details on material changes versus the prior comparable period. Investors must refer to the referenced press release for comparative financial analysis.
Guidance, Outlook, and Risks
Management commentary, forward-looking guidance, specific risks, contingencies, and unusual items are not detailed in the Form 8-K cover page. The document notes that the information in Item 2.02 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference except as expressly set forth.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated May 13, 2026) for actual Q1 2026 financial results.
- Verify specific revenue, net loss, and cash burn figures against the prior year quarter.
- Confirm the company's current cash position and runway based on the full press release.
- Check for any updated guidance or operational milestones mentioned in the press release.